ArticleJournal of fluorescence2026
Synthesis, In Vitro Antimicrobial Assessment, and Molecular Docking Investigations of Some Derived Compounds From Porphyrins.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porphyrins and their derivatives constitute a class of macrocyclic compounds of major interest in chemistry, biology, and medicine due to their remarkable structural and functional properties. In this work, we describe the synthesis of three substituted porphyrin derivatives obtained using classical and optimized methods. Spectroscopic characterization was performed using UV-Visible, infrared (IR), and nuclear magnetic resonance (NMR) spectroscopy, which confirmed the molecular structures of the porphyrin systems. In addition, a comparative study of the biological activity of these derivatives was carried out, highlighting their potential in several fields such as antimicrobial activity (antibacterial and antifungal) as well as antibiofilm activity. In addition, molecular docking studies against the targeted receptors (pdb: 3u2d, pdb: 1kzn, and pdb: 6y98) were performed. These investigations provided critical information about the binding mechanisms of the synthesized porphyrin derivatives towards selected receptors. Significant results were obtained, especially with compound 3b.
Indexed as
Identifiers
42530758What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.